Lv4
540 积分 2023-12-17 加入
A novel FAK-targeted degrader: Design, synthesis, and therapeutic potential against colorectal cancer
19天前
已完结
Rational Prediction of PROTAC-compatible Protein-Protein Interfaces by Molecular Docking
2个月前
已完结
In Silico Modeling of PROTAC-Mediated Ternary Complexes: Validation and Application
2个月前
已完结
Discovery of the First-in-Class Protein Arginine Methyltransferase 1 PROTAC Degrader
2个月前
已完结
Discovery of Novel PROTAC-Based HPK1 Degraders with High Potency and Selectivity for Cancer Immunotherapy
2个月前
已完结
Identification of a Potent and Selective Focal Adhesion Kinase Proteolysis Targeting Chimera: Targeting Noncatalytic Functions of Focal Adhesion Kinase to Facilitate Antitumor Immunity
2个月前
已完结
A novel FAK-degrading PROTAC molecule exhibited both anti-tumor activities and efficient MDR reversal effects
2个月前
已完结
Targeting focal adhesion kinase (FAK) for cancer therapy: FAK inhibitors, FAK-based dual-target inhibitors and PROTAC degraders
2个月前
已完结
Sex Differences in Disease Characteristics and Outcome in Adults with Acute Myeloid Leukemia from China
2个月前
已关闭
JAK3 inhibitors for the treatment of inflammatory and autoimmune diseases: a patent review (2016–present)
3个月前
已完结
皖公网安备34019202002308
